PPT-Migraine The comorbidity burden of chronic migraine

plt005 plt001 p0001 values shown in black are odds ratios comparing chronic migraine and episodic migraine AMPPAmerican Migraine Prevalence and Prevention COPDchronic obstructive pulmonary disease PHQ9Patient Health Questionnaire 9 items. Kevin M Kapadia, MD. Meriter Medical Group Neurology. Madison, WI. Objectives. Headache Disorders comprise a large portion of inpatient and outpatient primary care, pain medicine, and neurologic care, of which migraine headache disorders are one of the most common.. Care. Duren Michael Ready, MD FAHS ADAAPM. Director, Headache Clinic. Baylor Scott & White central division. DMReady@tamhsc.edu. Disclosures. Family Physician. Certified in Headache Medicine. Advanced . This program will include a discussion of data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Introduction to CGRP as a Treatment Target in Migraine Prevention. This program will include a discussion of data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Introduction to CGRP as a Treatment Target in Migraine Prevention. By Tammy Butler, Pharm.D.. Disclosure . Presenter is not affiliated with any manufacturers of the mentioned products or devices in this presentation. . Objectives. Learning Objectives (Pharmacist):. Learning Objectives (Pharmacy Technician):. Objective: Chronic migraine is a disabling disease, with high impact in their quality of life1. Current prophylactic treatments are often not effective or bad tolerated2. Glutamate is elevated in chro Treating physician finds the condition stable on current regimen and no changes recommended [ ] Yes Acceptable s of Migraine or Headache [ ] Classic /Common Migraine , Chronic Tension hea 1. Prevalence of chronic conditions in patients with MDD. A retrospective analysis of patient data was performed to compare the prevalence of chronic conditions in patients with depression and the general population. Comorbidity adjustments were calculated in the following order: 1. . Green. , 2. . Blue. , 3. . Red. , 4. . Orange. . For SMDs and OMDs prevalence was summated without comorbidity adjustments due to low prevalence (<1%). Personality disorders were adjusted for at the SMD, CMD and OMD levels of aggregation.. The Impact of Different SEERMedicare Claims-based Comorbidity Indexes on Predicting Non Authors Margaret R. Stedman, PhD 1,2; Paul DoriaRose, PhD; Joan L. Warren, PhD ; Angela Mariotto, PhD 2 1 Sta 1. Migraine. Migraine epidemiology. An estimated 1.3 billion individuals across the globe were estimated to have migraine in 2017. 1. In the WHO Global Burden of Disease study, ‘headache disorders’ has consistently been the 2. Migraine without aura. ≥5 . attacks. lasting . 4–72 hours . when untreated. ≥. 2 . of the following. : . Unilateral location. Pulsating quality. Moderate-to-severe pain. Aggravation by physical activity. AMPP=American Migraine Prevalence and Prevention; COPD=chronic obstructive pulmonary disease; MHD=monthly headache day. 1. Buse et al. Headache 2020;60(10):2340–2356. Prevalence of various comorbidities among people with migraine based on headache frequency . An electronic diary study followed 62 people with migraine over 3 months. 1. The most the frequent trigger factors on headache days were . stress. , . fatigue. , and . sleep deprivation. 1. Headaches with trigger factors were more severe than those without trigger factors.